Oscillating devices for airway clearance in people with cystic fibrosis

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 5, 2017, Pages

  Morrison, Lisa ^a   Innes, Stephanie ^a  

^a QUEEN ELIZABETH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; BREATHING EXERCISE; CHEST WALL OSCILLATION; COCHRANE LIBRARY; CYSTIC FIBROSIS; DISEASE EXACERBATION; FORCED EXPIRATORY VOLUME; HUMAN; LUNG CLEARANCE; LUNG FUNCTION; META ANALYSIS; MUCOCILIARY CLEARANCE; PATIENT SATISFACTION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REHABILITATION EQUIPMENT; REVIEW; SPUTUM; SYSTEMATIC REVIEW; WEIGHT; WORLD HEALTH ORGANIZATION; ADOLESCENT; ADULT; CHILD; COMPLICATION; DEVICES; DISEASE COURSE; FORCED EXPIRATORY FLOW; LUNG DISEASES, OBSTRUCTIVE; MIDDLE AGED; MUCUS; PATHOPHYSIOLOGY; SECRETION (PROCESS); THERAPEUTIC USE; VIBRATION;

ADOLESCENT; ADULT; BREATHING EXERCISES; CHEST WALL OSCILLATION; CHILD; CYSTIC FIBROSIS; DISEASE PROGRESSION; FORCED EXPIRATORY FLOW RATES; FORCED EXPIRATORY VOLUME; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MIDDLE AGED; MUCOCILIARY CLEARANCE; MUCUS; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPUTUM; VIBRATION;

EID: 85018744141     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD006842.pub4     Document Type: Review

References (155)

1. App EM, Danzl G, Schweiger K, Kieselmann R, Reinhardt D, Lindemann H, et al. Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy - VRP1 (flutter) versus autogenic drainage [abstract]. American Journal of Respiratory and Critical Care Medicine. 1995; Vol. 151, issue 4 Suppl:A737. 3312501
2. App EM, Kieselmann R, Reinhardt D, Lindemann H, Dasgupta B, King M, et al. Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy: flutter vs autogenic drainage. Chest 1998;114(1):171-7. 3312502
3. Arens R, Gozal D, Omlin KJ, Vega J, Boyd KP, Keens TG, et al. Comparison of high frequency chest compression and conventional chest physiotherapy in hospitalized patients with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine 1994;150(4):1154-7. 3312504
4. Arens R, Gozal D, Omlin KJ, Vega J, Boyd KP, Woo MS, et al. Comparative efficacy of high frequency chest compression and conventional chest physiotherapy in hospitalized patients with cystic fibrosis. Pediatric Pulmonology. 1993; Vol. Suppl 9:239. 3312505
5. Braggion C, Cappelletti LM, Cornacchia M, Zanolla L, Mastella G. Short-term effects of three chest physiotherapy regimens in patients hospitalized for pulmonary exacerbations of cystic fibrosis: a cross-over randomized study. Pediatric Pulmonology 1995;19(1):16-22. 3312507
6. Cappelletti LM, Cornacchia M, Braggion C, Zanolla L, Mastella G. Short-term effects of 3 physiotherapy (CPT) regimens in cystic fibrosis (CF) patients hospitalized for a pulmonary exacerbation: a cross-over randomized trial. In: Proceedings of 18th European Cystic Fibrosis Conference; 1993 May 21-26; Madrid, Spain. 1993:W9.3. 3312508
7. Darbee JC, Kanga JF, Ohtake PJ. Physiologic Eeidence for high-frequency chest wall oscillation and positive expiratory pressure breathing in hospitalized subjects with cystic fibrosis. Physical Therapy 2005;85(12):1278-89. 3312510
8. Darbee JC, Kanga JF, Ohtake PJ. Physiologic evidence for high frequency chest wall oscillation and positive expiratory pressure breathing in hospitalized patients with cystic fibrosis. Pediatric Pulmonology 2005;40(Suppl 28):322. 3312511
9. Banks A, Davies G, Agent P, Osman L, Bilton D, Hodson M. The use of high frequency chest wall oscillation during an acute infective pulmonary exacerbation of cystic fibrosis. European Respiratory Journal 2012;40. [Abstract no: 3483; CENTRAL: 1100493; CFGD Register: PE197b; CRS: 5500050000000359; EMBASE: 71925445]5574048
10. Davies GA, Banks AE, Agent P, Osman LP, Bilton D, Hodson ME. The use of high frequency chest wall oscillation during an acute infective pulmonary exacerbation of cystic fibrosis. Pediatric Pulmonology 2012;47(S35):366. [Abstract no: 396; CFGD Register: PE197a; ]3312678
11. Giles D, Sontag M, Wagener J, Accurso F. Effect of one month of treatment with flutter valve or postural drainage and clapping on pulmonary function and sputum recovery in cystic fibrosis. Pediatric Pulmonology. 1996; Vol. Suppl 13:307. 3312513
12. Gondor M, Nixon PA, Mutich R, Rebovich P, Orenstein DM. Comparison of flutter device and chest physical therapy in the treatment of cystic fibrosis pulmonary exacerbation. Pediatric Pulmonology 1999;28(4):255-60. 3312515
13. Gondor M, Nixon PA, Rebovich PJ, Orenstein DM. A comparison of the flutter device and chest physical therapy in the treatment of cystic fibrosis pulmonary exacerbation. Pediatric Pulmonology 1996;Suppl 13:307. 3312516
14. Gotz M, Wolkerstorfer A. Physiotherapy in cystic fibrosis: Intrapulmonary percussive ventilation (IPV) versus positive expiratory pressure (PEP). Pediatric Pulmonology 1995;20(Suppl 12):267. 3312518
15. Grzincich GL, Longon F, Faverzani S, Chetta A, Spaggiari C, Pisi G. Short-term effects of high-frequency chest compression (HFCC) and positive expiratory pressure (PEP) in adults with cystic fibrosis. Proceedings of European Respiratory Society Annual Congress; 2008 Oct 4-8; Berlin, Germany. 2008:502s. 3312520
16. Hansen LG, Warwick WJ. High-frequency chest compression system to aid in clearance of mucus from the lung. Biomedical Instrumentation & Technology 1990;24(4):289-94. 3312522
17. Hare KL, Homnick DN, Cucos D, Marks JH. The PercussiveTech HF device compared to standard chest physiotherapy in hospitalized patients with cystic fibrosis. Pediatric Pulmonology 2002;Suppl 24:316. 3312524
18. Homnick D, Spillers C, White F. The intrapulmonary percussive ventilator compared to standard aerosol therapy and chest physiotherapy in the treatment of patients with cystic fibrosis. Pediatric Pulmonology 1994;Suppl 10:266. 3312526
19. Homnick DN, White F, de Castro C. Comparison of effects of an intrapulmonary percussive ventilator to standard aerosol and chest physiotherapy in treatment of cystic fibrosis. Pediatric Pulmonology 1995;20(1):50-5. [MEDLINE: 1999007053]3312527
20. Homnick DN, Anderson K, Marks JH. Comparison of the flutter device to standard chest physiotherapy in hospitalized patients with cystic fibrosis: a pilot study. Chest 1998;114(4):993-7. [MEDLINE: 1999007053]3312529
21. Homnick DN, Marks JH. Comparison of the flutter device to standard chest physiotherapy in hospitalized patients with cystic fibrosis. Pediatric Pulmonology 1996;Suppl 13:308. 3312530
22. Khan MA, Lian NA, Mikitchenko NA. The use of high-frequency chest wall oscillation for the combined treatment of the children presenting with mucoviscidosis. Voprosy Kurortologii, Fizioterapii, i Lechebnoi Fizicheskoi Kultury 2014, (3):22-6. [CFGD Register: PE227; CRS: 5500135000001513; PUBMED: 25087417]5574050
23. Kluft J, Beker L, Castagnino M, Gaiser J, Chaney H, Fink RJ. A comparison of bronchial drainage treatments in cystic fibrosis. Pediatric Pulmonology 1996;22(4):271-4. [MEDLINE: 97061859]3312532
24. Lyons E, Chatham K, Campbell IA, Prescott RJ. Evaluation of the flutter VRP1 device in young adults with cystic fibrosis. 11th International Cystic Fibrosis Congress; 1992; Dublin, Ireland. 1992:AHP30. 3312534
25. Lyons E, Chatham K, Campbell IA, Prescott RJ. Evaluation of the flutter VRP1 device in young adults with cystic fibrosis. Thorax 1992;47(3):237P. [CFGD Register: PE60b]3312535
26. Marks JH, Hare K, Homnick DN. The PercussiveTech HF compared to the flutter in cystic fibrosis patients: a six month pilot study. Proceedings of 24th European Cystic Fibrosis Conference; 2001 June 6-9; Vienna, Austria. 2001:P101. 3312537
27. Marks JH, Homnick DN, Hare K, Cucos D. The PercussiveTech HF compared to the flutter device in cystic fibrosis patients: a six month pilot study. Pediatric Pulmonology 2001;32(Suppl 22):309. 3312538
28. Davidson AGF, McIlwaine PM, Wong LTK, Peacock D. "Flutter versus PEP": A long-term comparative trial of positive expiratory pressure (PEP) versus oscillating positive expiratory pressure (Flutter) physiotherapy techniques. In: Proceedings of 22nd European Cystic Fibrosis Conference; 1998 June 13-19; Berlin, Germany. 1998:71. 3312540
29. McIlwaine PM, Wong LT, Peacock D, Davidson AG. Long-term comparative trial of positive expiratory pressure versus oscillating positive expiratory pressure (flutter) physiotherapy in the treatment of cystic fibrosis. Journal of Pediatrics 2001;138(6):845-50. 3312541
30. McIlwaine PM, Wong LTK, Peacock D, Davidson AGF. "Flutter versus PEP": A long-term comparative trial of positive expiratory pressure (PEP) versus oscillating positive expiratory pressure (FLUTTER) physiotherapy. Pediatric Pulmonology 1997;23(Suppl 14):299. 3312542
31. Alarie N, Agnew JL, McIlwaine M, Ratjen F, Davidson G, Lands LC. Canadian National Airway Clearance Study: how physically active are CF patients?. Pediatric Pulmonology 2012;47(S35):367. [Abstract no: 398; CFGD Register: PE187e; ]3312544
32. Alarie N, Agnew LL, McIlwaine MP, Ratjen F, Davidson GF, Milner R, et al. Evaluation of physical activity using the habitual activity estimation scale (HAES) questionnaire in a multicenter study. Journal of Cystic Fibrosis 2013;12 Suppl 1:S28. [Abstract no: WS14.1; CFGD Register: PE187f; ]3312545
33. McIlwaine M, Agnew J, Alarie N, Ratjen F, Lands L, Milner R, et al. Canadian national airway clearance study: patient satisfaction with positive expiratory pressure versus high frequency chest wall oscillation. Pediatric Pulmonology 2012;47(S35)(S35):367. [Abstract no: 397; CFGD Register: PE187b; ]3312546
34. McIlwaine M, Agnew JL, Alarie N, Lands L, Ratjen F, Milner R, et al. Canadian national airway clearance study: positive expiratory pressure mask versus high frequency chest wall oscillation. Journal of Cystic Fibrosis 2012;11 Supplement 1:S23. [Abstract no: WS10.6; CFGD Register: PE187a]3312547
35. McIlwaine MP, Alarie N, Davidson GF, Lands LC, Ratjen F, Milner R, et al. Long-term multicentre randomised controlled study of high frequency chest wall oscillation versus positive expiratory pressure mask in cystic fibrosis. Thorax 2013;68(8):746-51. [CFGD Register: PE187c; ]3312548
36. McIlwaine MP, Alarie N, Davidson GF, Lands LC, Ratjen F, Milner R, et al. Online Supplement to "Long-term multicentre randomised controlled study of high frequency chest wall oscillation versus positive expiratory pressure mask in cystic fibrosis" [online]. Thorax 2013;68(8):746-51 Online. [CFGD Register: PE187d; ]3312549
37. Milne SM, Eales CJ. A pilot study comparing two physiotherapy techniques in patients with cystic fibrosis. South African Journal of Physiotherapy 2004;60(2):3-6. 3312551
38. Accurso FJ, Sontag MK, Koenig JM, Quittner AL. Multi-center airway secretion clearance study in cystic fibrosis. Pediatric Pulmonology 2004;38(Suppl 27):314. 3312553
39. Modi AC, Cassedy AE, Quittner AL, Accurso F, Sontag M, Koenig JM, et al. Trajectories of adherence to airway clearance therapy for patients with cystic fibrosis. Journal of Pediatric Psychology 2010;35(9):1028-37. [CFGD Register: PE152e]3312554
40. Modi AC, Sontag MK, Koenig JM, Accurso FJ, Quittner AL, Investigators and Coordinators of the Airway Secretion Clearance Study. Adherence to airway clearance therapies in patients with cystic fibrosis. Journal of Cystic Fibrosis 2006;5 Suppl:S97. 3312555
41. Quittner AL, Modi AC, Accurso FJ, Koenig JM, Sontag MK, Oermann C, et al. Treatment satisfaction, health-related quality of life and airway clearance therapies in patients with cystic fibrosis. Pediatric Pulmonology 2004;38(Suppl 27):314. 3312556
42. Sontag MK, Quittner AL, Modi AC, Koenig JM, Giles D, Oermann CM, et al. Lessons learned from a randomized trial of airway secretion clearance techniques in cystic fibrosis. Pediatric Pulmonology 2010;45(3):291-300. 3312557
43. Accurso FJ, Sontag MK, Koenig JM, Quittner AL. Multi-center airway secretion clearance study in cystic fibrosis. Pediatric Pulmonology 2004;38(Suppl 27):314. 3312559
44. Modi AC, Cassedy AE, Quittner AL, Accurso F, Sontag M, Koenig JM, et al. Trajectories of adherence to airway clearance therapy for patients with cystic fibrosis. Journal of Pediatric Psychology 2010; Vol. 35, issue 9:1028-37. [CFGD Register: PE152e]3312560
45. Modi AC, Sontag MK, Koenig JM, Accurso FJ, Quittner AL, Investigators and Coordinators of the Airway Secretion Clearance Study. Adherence to airway clearance therapies in patients with cystic fibrosis. Journal of Cystic Fibrosis 2006;5 Suppl:S97. 3312561
46. Quittner AL, Modi AC, Accurso FJ, Koenig JM, Sontag MK, Oermann C, et al. Treatment satisfaction, health-related quality of life and airway clearance therapies in patients with cystic fibrosis. Pediatric Pulmonology 2004;38(Suppl 27):314. 3312562
47. Sontag MK, Quittner AL, Modi AC, Koenig JM, Giles D, Oermann CM, et al. Lessons learned from a randomized trial of airway secretion clearance techniques in cystic fibrosis. Pediatric Pulmonology 2010;45(3):291-300. 3312563
48. Newbold ME, Brooks D, Tullis DE, Ross BG. Effectiveness of the flutter device versus the PEP mask in the treatment of adult cystic fibrosis. Pediatric Pulmonology 2000;30(Suppl 20):304. 3312565
49. Newbold ME, Tullis E, Corey, M, Ross B, Brooks D. The flutter device versus the PEP mask in the treatment of adults with cystic fibrosis. Physiotherapy Canada 2005;57(3):199-207. 3312566
50. Oermann CM, Sockrider MM, Giles D, Sontag MK, Accurso FJ, Castile RG. Comparison of high-frequency chest wall oscillation and oscillating positive expiratory pressure in the home management of cystic fibrosis: a pilot study. Pediatric Pulmonology 2001;32(5):372-7. 3312568
51. Osman LP, Roughton M, Hodson ME, Pryor JA. High frequency chest wall oscillation in cystic fibrosis. Journal of Cystic Fibrosis 2008;7(Suppl 2):295. [CFGD Register: PE171a]3312577
52. Osman LP, Roughton M, Hodson ME, Pryor JA. Short-term comparative study of high frequency chest wall oscillation and European airway clearance techniques in patients with cystic fibrosis. Thorax 2010;65(3):196-200. [CFGD Register: PE171b; ]3312578
53. Padman R, Geouque DM, Engelhardt MT. Effects of the flutter device on pulmonary function studies among pediatric cystic fibrosis patients. Delaware Medical Journal 1999;71(1):13-8. 3312580
54. Padman R, Geouque DM, Engelhardt MT. Effects of the flutter device on pulmonary function studies among pediatric cystic fibrosis patients. Delaware Medical Journal 1999;71(1):13-8. 3312582
55. Phillips GE, Pike S, Jaffe A, Bush A. Comparison of the active cycle of breathing techniques and external high frequency oscillation jacket for clearance of secretions in children with cystic fibrosis. Thorax 1998;53(Suppl 4):A61. 3312584
56. Phillips GE, Pike SE, Jaffe A, Bush A. Comparison of active cycle of breathing and high-frequency oscillation jacket in children with cystic fibrosis. Pediatric Pulmonology 2004;37(1):71-5. 3312585
57. Pike SE, Machin AC, Dix KJ, Pryor JA, Hodson ME. Comparison of flutter VRPI and forced expirations (FE) with active cycle of breathing techniques (ACBT) in subjects with cystic fibrosis (CF). The Netherlands Journal of Medicine 1999;54(Suppl):S55-6. 3312587
58. Main E, Tannenbaum E, Stanojevic S, Scrase E, Prasad A. The effects of positive expiratory pressure (PEP) or oscillatory positive pressure (RC Cornet®) on FEV1 and lung clearance index over a twelve month period in children with CF. Pediatric Pulmonology 2006;41(Suppl 29):351. 3312589
59. Prasad A, Tannenbaum E, Bryon M, Main E. One year trial of two airway clearance techniques in children with cystic fibrosis: limitations of the quality of well-being scale. Pediatric Pulmonology 2005;40(Suppl 28):323. 3312590
60. Tannenbaum E, Prasad SA, Main E, Scrase E. Long-term effects of positive expiratory pressure (PEP) or oscillatory positive pressure (RC Cornet®) on FEV1 and perceived health in children with CF. Proceedings of 28th European Cystic Fibrosis Conference; 2005 June 22-25; Crete, Greece. 2005:S100. 3312591
61. Pryor JA, Webber BA, Hodson ME, Warner JO. The Flutter VRP1 as an adjunct to chest physiotherapy in cystic fibrosis. 11th International Cystic Fibrosis Congress; 1992; Dublin, Ireland. 1992:WP 102. 3312593
62. Pryor JA, Webber BA, Hodson ME, Warner JO. The Flutter VRP1 as an adjunct to chest physiotherapy in cystic fibrosis. Respiratory Medicine 1994;88(9):677-81. 3312594
63. Pryor JA, Tannenbaum E, Cramer D, Scott SF, Burgess J, Gyi K, et al. A comparison of five airway clearance techniques in the treatment of people with Cystic Fibrosis [abstract]. Journal of Cystic Fibrosis 2006;5(Suppl):S76. 3312596
64. Pryor JA, Tannenbaum E, Scott SF, Burgess J, Cramer D, Gyi K, et al. Beyond postural drainage and percussion: Airway clearance in people with cystic fibrosis. Journal of Cystic Fibrosis 2010;9(3):187-92. 5574051
65. van Winden CMQ, Visser A, Hop W, Sterk PJ, Beckers S, de Jongste JC. Effects of Flutter and PEP-MASK on expectoration and lung function in cystic fibrosis. Israel Journal of Medical Sciences 1996;32(Suppl):S275. 3312598
66. van Winden CMQ, Visser A, Hop W, Sterk PJ, Beckers S, de Jongste JC. Effects of flutter and PEP mask physiotherapy on symptoms and lung function in children with cystic fibrosis. European Respiratory Journal 1998;12(1):143-7. 3312599
67. Castile R, Tice J, Flucke R, Filbrun D, Varekojis S, McCoy K. Comparison of three sputum clearance methods in in-patients with cystic fibrosis. Pediatric Pulmonology 1998;26(Suppl 17):329. [MEDLINE: 97221261]3312601
68. Varekojis SM, Douce FH, Flucke RL, Filbrun DA, Tice JS, McCoy KS, et al. A comparison of the therapeutic effectiveness of and preference for postural drainage and percussion, intrapulmonary percussive ventilation, and high-frequency chest wall compression in hospitalized cystic fibrosis patients. Respiratory Care 2003;48(1):24-8. 3312602
69. Castile R, Tice J, Flucke R, Filbrun D, Varekojis S, McCoy K. Comparison of three sputum clearance methods in in-patients with cystic fibrosis. Pediatric Pulmonology 1998;26(Suppl 17):329. [MEDLINE: 97221261]3312604
70. Varekojis SM, Douce FH, Flucke RL, Filbrun DA, Tice JS, McCoy KS, et al. A comparison of the therapeutic effectiveness of and preference for postural drainage and percussion, intrapulmonary percussive ventilation, and high-frequency chest wall compression in hospitalized cystic fibrosis patients. Respiratory Care 2003;48(1):24-8. 3312605
71. Warwick WJ, Wielnski CI. Matched pair comparison of manual chest physical therapy (CPT) and the thairapy bronchial drainage vest (ThBVD) system. Pediatric Pulmonology 1990;9 Suppl 5:177. 3312607
72. Warwick WJ, Wielinski CL, Hansen LG. Comparison of expectorated sputum after manual chest physical therapy and high-frequency chest compression. Biomedical Instrumentation Technology 2004;38(6):470-5. 3312609
73. West K, Wallen M, Follett J. Acapella vs. PEP mask therapy: a randomised trial in children with cystic fibrosis during respiratory exacerbation. Physiotherapy Theory and Practice 2010;26(3):143-9. [CENTRAL: 753270; CFGD Register: PE213; CRS: 5500050000000049; PUBMED: 20331370]5574053
74. Amelina EL, Krasovskii SA, Usacheva MV, Krylova NA. [Use of high-frequency chest wall oscillation in an exacerbation of chronic pyo-obstructive bronchitis in adult patients with cystic fibrosis]. [Russian]. Terapevticheskii Arkhiv 2014;86(12):33-6. [CFGD Register: PE226b; CRS: 5500135000000122; PUBMED: 25804037]5574055
75. Krasovskij S, Amelina E, Usacheva M, Samoylenko V, Krilova N. High frequency chest wall oscillation (HFCWO) in the treatment of acute pulmonary exacerbation in adult cystic fibrosis (CF) patients. European Respiratory Society Annual Congress; 2013 Sept 7-11; Barcelona, Spain 2013;42:741s. [Abstract no: P3599; CENTRAL: 990024; CFGD Register: PE226a; CRS: 5500050000000365]5574056
76. Borka P, Gyurkovits K, Bódis J. Comparative study of PEP mask and Flutter on expectoration in cystic fibrosis patients. Acta Physiologica Hungarica 2012;99(3):324-331. 3312611
77. Cantin AM, Berthiaume Y. Clearance of airway secretions with the Frequencer in patients with cystic fibrosis. Pediatric Pulmonology 2004;38(Suppl 27):322. 3312613
78. Cegla UH, Retzow A. Physical therapy with VRP1 in chronic obstructive respiratory tract diseases--results of a multicenter comparative study [Physiotherapie mit dem VRP1 bei chronisch obstruktiven Atemwegserkrankungen--Ergebnisse einer multizentrischen Vergleichsstudie]. Pneumologie 1993;47(11):636-9. 3312615
79. Dosman CF, Zuberbuhler PC, Tabak JI, Jones RL. Effects of positive end-expiratory pressure on oscillated volume during high frequency chest compression in children with cystic fibrosis. Canadian Respiratory Journal 2003;10(2):94-8. [CFGD Register: PE144; ]3312617
80. Dunn C, Davies Z, Everson C, Zirbes J, Kim L, Milla C. Study of acute effects on pulmonary function and sputum production with high frequency chest oscillation (HFCWO) and postural drainage aided by handheld percussion (P-HP). Pediatric Pulmonology 2013;48 Suppl 36:359. [Abstract no: 421; CFGD Register: PE205b; ]3312619
81. Dunn C, Davies Z, Kim L, Zirbes J, Everson C, Milla C. Comparison of acute effects of conventional high frequency chest oscillation (HFCWO) and hand held percussor (Electro-Flo 5000) for airway clearance in cystic fibrosis patients. Journal of Cystic Fibrosis 2013;12 Suppl 1:S103. [Abstract no: 215; CFGD Register: PE205a; ]3312620
82. Dwyer TJ, Zainuldin R, Daviskas E, Bye PT, Alison JA. Effects of treadmill exercise versus Flutter(R) on respiratory flow and sputum properties in adults with cystic fibrosis: a randomised, controlled, cross-over trial. BMC Pulmonary Medicine 2017;17(1):14. [CFGD Register: PE239 ; CRS: 5500135000001880; PUBMED: 28077104]5574058
83. Elkins MR, Eberl S, Alison J, Bye P. The effect of bi-level non-invasive ventilation on mucociliary clearance in subjects with cystic fibrosis. Pediatric Pulmonology 2004;38(Suppl 27):315. 3312622
84. Elkins MR, Eberl S, Constable C, White J, Robinson M, Daviskas E, et al. The effect of manual chest physiotherapy, positive expiratory pressure (PEP), and oscillating PEP on mucociliary clearance in subjects with cystic fibrosis. Pediatric Pulmonology 2005;40(Suppl 28):321. 3312624
85. Fainardi V, Longo F, Faverzani S, Tripodi MC, Chetta A, Pisi G. Short-term effects of high-frequency chest compression and positive expiratory pressure in patients with cystic fibrosis. Journal of Clinical Medicine Research 2011;3(6):279-84. [CENTRAL: 983057; CFGD Register: PE211; CRS: 5500125000000625; PUBMED: 22393338]5574060
86. Grosse-Onnebrink J, Mellies U, Olivier M, Werner C, Stehling F. Chest physiotherapy can affect the lung clearance index in cystic fibrosis patients. Pediatric Pulmonology 2017;52(5):625-31. [CENTRAL: 1343708; CFGD Register: PE238; CRS: 5500135000001898; PUBMED: 28125158]5574062
87. Hartsell M, Traver G, Taussig LM. Comparison of manual percussion and vibration (P &V) vs. mechanical vibration (MV) alone on maximal expiratory flows. 19th Cystic Fibrosis Club Abstracts. 1978:49. 3312626
88. Jarad NA, Powell T, Smith CE, Cartwright P, Nedwell J. The efficacy, preference and safety of a novel method of sputum clearance, hydro acoustic therapy, on adult patients with cystic fibrosis. Thorax 2006;61(Suppl 2):ii120; P194. [CFGD Register: PE172a]3312628
89. Jarad NA, Powell T, Smith E. Evaluation of a novel sputum clearance technique--hydro-acoustic therapy (HAT) in adult patients with cystic fibrosis: a feasibility study. Chronic Respiratory Diseases 2010;7(4):217-27. [CFGD Register: PE172b]3312629
90. Kempainen R, Hazelwood A, Williams C, Dunitz J, Billings J, Milla C. Comparison of airway clearance efficacy of sine and triangular wave high frequency chest wall oscillation in patients with cystic fibrosis. Pediatric Pulmonology 2006;41 Suppl 29:351. [CFGD Register: PE166a]5574064
91. Kempainen RR, Milla C, Dunitz J, Savik K, Hazelwood A, Williams C, et al. Comparison of settings used for high-frequency chest-wall compression in cystic fibrosis. Respiratory Care 2010;55(6):695-701. [CENTRAL: 761016; CFGD Register: PE166c; CRS: 5500050000000193; PUBMED: 20507651]5574065
92. Kempainen RR, Williams CB, Hazelwood A, Rubin BK, Milla CE. Comparison of high-frequency chest wall oscillation with differing waveforms for airway clearance in cystic fibrosis. Chest 2007;132(4):1227-32. [CFGD Register: PE166b]5574066
93. Kirkpatrick KR, Howard D, Ter-Pogossian M, Kollef MH. A direct comparison of manual chest percussion with acoustic percussion, an experimental treatment for cystic fibrosis [abstract]. American Journal of Respiratory and Critical Care Medicine 1995;151(4 Suppl):A738. 3312635
94. Konstan MW, Stern RC, Doershuk CF. Efficacy of the Flutter device for airway mucus clearance in patients with cystic fibrosis. Journal of Pediatrics 1994;124(5 (Pt 1)):689-93. 3312631
95. Kraemer D, Liedtke C, Casaulta Aebischer C. Bronchodilator inhalation (BD) treatment in sequence with flutter VRP1 chest physiotherapy (CPT) in patients with cystic fibrosis. Israel Journal of Medical Sciences 1996;32(Suppl):S192. 3312633
96. Lagerkvist AL, Sten G, Lindblad A, Redfors S. Chest physiotherapy with positive expiratory pressure (PEP) and oscillating positive expiratory pressure (flutter) in patients with cystic fibrosis-a comparative study. Proceedings of 21st European Cystic Fibrosis Conference; 1997 June 1-6; Davos, Switzerland. 1997:132. 3312637
97. Lagerkvist AL, Sten GM, Redfors SB, Lindblad AG, Hjalmarson O. Immediate changes in blood-gas tensions during chest physiotherapy with positive expiratory pressure and oscillating positive expiratory pressure in patients with cystic fibrosis. Respiratory Care 2006;51(10):1154-61. 3312638
98. Liedtke D, Casaulta Aebischer C, Martin N, Schibler A, Kraemer R. Mucociliar clearance (MCC) in patients with cystic fibrosis (CF) - Efficacy of beta2-inhalation therapy (beta2) in combination with respiratory physiotherapy [abstract] [Mukoziliare Clearance bei (MCC) bei Patienten mit cystischer Fibrose (CF) - Effizienz der beta2-Inhalationstherapie (beta2) in Kombination mit Atemphysiotherapie (APT)]. Schweizerische Medizinische Wochenschrift 1996;126(Suppl 78):29S. 3312640
99. Lindemann H. The value of physical therapy with VRP 1-Desitin ("Flutter") [Zum Stellenwert der Physiotherapie mit dem VRP 1-Desitin ("Flutter")]. Pneumologie 1992;46(12):626-30. 3312642
100. Majaesic CM, Montgomery M, Jones R, King M. Reduction in sputum viscosity using high frequency chest compressions (HFCC) compared to conventional chest physiotherapy (CCP). Pediatric Pulmonology 1996;Suppl 13:308. 3312644
101. Marks JH, Fooy C, Anderson K, Homnick DN. Nebulized albuterol delivered with positive expiratory pressure (PEP) and the flutter device in patients with cystic fibrosis: an assessment of bronchodilator response compared to standard nebulizer therapy. American Journal of Respiratory and Critical Care Medicine. 1998; Vol. 157, issue 3 Suppl:A130. 3312646
102. Marks J, Hare K, Homnick D. The PercussiveTech HF device compared to standard chest physiotherapy in patients with cystic fibrosis. Proceedings of 13th International Cystic Fibrosis Congress; 2000 June 4-8; Stockholm, Sweden. 2000:151. 3312650
103. Marks JH, Hare KL, Homnick DN. Pulmonary function and sputum production in patients with cystic fibrosis: a pilot study comparing the percussive tech HF device and standard chest physiotherapy. Pediatric Pulmonology 1999;28(Suppl 19):290. 3312651
104. Marks JH, Hare KL, Saunders RA, Homnick DN. Pulmonary function and sputum production in patients with cystic fibrosis: a pilot study comparing the PercussiveTech HF device and standard chest physiotherapy. Chest 2004;125(4):1507-11. 3312652
105. McCarren B, Alison JA. Comparison of vibration to other physiotherapy interventions for secretion clearance. European Respiratory Journal 2005;26(Suppl 49):497s. 3312654
106. McCarren B, Alison JA. Physiological effects of vibration in subjects with cystic fibrosis. European Respiratory Journal 2006;27(6):1204-9. 3312655
107. Morris D, Barbero G, Konig P, Woodruff C, Kline J, Martinez R. The effect of mechanical and manual percussion on pulmonary function in cystic fibrosis patients. 23rd Annual Meeting Cystic Fibrosis Club Abstracts; 1982 May 14; Washington D.C. 1982:135. 3312657
108. Natale JE, Pfeifle J, Homnick DN. Comparison of intrapulmonary percussive ventilation and chest physiotherapy. A pilot study in patients with cystic fibrosis. Chest 1994;105(6):1789-93. 3312659
109. Newhouse P, White F, Marks J, Homnick D. Pulmonary function testing and sputum production in patients with cystic fibrosis: A pilot study comparing the flutter device, intrapulmonary percussive ventilator, and standard chest physiotherapy. Pediatric Pulmonology 1995;Suppl 12:269. 3312661
110. Newhouse PA, White F, Marks JH, Homnick DN. The intrapulmonary percussive ventilator and flutter device compared to standard chest physiotherapy in patients with cystic fibrosis. Clinical Pediatrics 1998;37(7):427-32. 3312662
111. O'Neil K, Moran F, Bradbury I, Downey DG, Rendall J, Tunney MM, et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax 2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677]5574068
112. O'Neill K, Moran F, Tunney MM, Elborn JS, Bradbury I, Downey DG, et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: Pilot data from a randomised crossover study. BMJ Open Respiratory Research 2017;4(1). [CENTRAL: 1297377; CFGD Register: BD231b; CRS: 5500135000001896; CTG: NCT01753869; EMBASE: 614069626]5574069
113. Orlik T. Evaluation of the efficiency of selected thoracic physiotherapy methods used in the treatment of patients with cystic fibrosis [Ocena efektywnosci wybranych metod fizjoterapii klatki piersiowej stosowanej w leczeniu chorych na mukowiscydoze]. Medycyna Wieku Rozwojowego 2000;4(3):233-46. 3312570
114. Orlik T. Estimation of autodrainage methods in a selected group of cystic fibrosis patients with home environment factors taken into consideration [Ocena metod autodren azu w wybranej grupie chorych na mukowiscydoze z uwzglednieniem czynnika strodowiskowego]. Medycyna Wieku Rozwojowego 2000;4(3):247-59. 3312572
115. Orlik T, Sands D. Long-term evaluation of effectiveness for selected chest physiotherapy methods used in the treatment of cystic fibrosis [Dlugofalowa ocena skutecznosci wybranych metod fizjoterapii klatki piersiowej stoswanych w leczeniu chorych na mukowiscydoze]. Medycyna Wieku Rozwojowego 2001;5(3):245-57. 3312574
116. Orlik T, Sands D. Long-term study of efficiencies of select physiotherapy methods used in the treatment of cystic fibrosis. Proceedings of 24th European Cystic Fibrosis Conference; 2001 June 6-9; Vienna, Austria. 2001:P113. 3312575
117. Roos S, Birrer P, Rüdeberg A, Kraemer R. First experience with intrapulmonary percussive ventilation (IPV) in the treatment of patients with cystic fibrosis. Proceedings of 15th Annual Meeting of the European Working Group for Cystic Fibrosis; 1987; Oslo, Norway. 1987. 3312664
118. Salh W, Bilton D, Dodd M, Webb AK. Effect of exercise and physiotherapy in aiding sputum expectoration in adults with cystic fibrosis. Thorax 1989;44(12):1006-8. 3312666
119. Scherer TA, Barandun J, Martinez E, Wanner A, Rubin EM. Effect of high-frequency oral airway and chest wall oscillation and conventional chest physical therapy on expectoration in patients with stable cystic fibrosis. Chest 1998;113(4):1019-27. [MEDLINE: 98213362]3312668
120. Skopnik H, Waters W, Horowitz AE, Roth B, Benz-Bohm G. Evaluation of Knock and Vibrattion Therapy and Autogenic drainage in Cystic Fibrosis Using a Ventilation Zintigraphical method [Beurteilung der Klopf und Vibrationstherapie und autogenic drainage bei cystischer fibrose mittels eines ventilationsszintigrafischen Verfahrens]. Monatsscurift fur Kinderheilkunde. 1986; Vol. 134:583. 3312670
121. Stites SW, Perry GV, Peddicord T, Cox G, McMillan C, Becker B. Effect of high-frequency chest wall oscillation on the central and peripheral distribution of aerosolized diethylene triamine penta-acetic acid as compared to standard chest physiotherapy in cystic fibrosis. Chest 2006;129(3):712-7. 3312672
122. Van Ginderdeuren F, Verbanck S, Van Cauwelaert K, Vanlaethem S, Schuermans D, Vincken W, et al. Chest physiotherapy in cystic fibrosis: short-term effects of autogenic drainage preceded by wet inhalation of saline versus autogenic drainage preceded by intrapulmonary percussive ventilation with saline. Respiration 2008;76(2):175-80. [CFGD Register: BD186]3312674
123. Webber BA, Parker RA, Hofmeyr JL, Hodson ME. Evaluation of self-percussion during postural drainage using the forced expiration technique (FET). Proceedings of 9th International Cystic Fibrosis Congress; 1984 June 9-15; Brighton, England. 1984:2.12. 3312676
124. Herrero Cortina B, San Miguel Pagola M, Cebria i Ranzo MA, Gomez Romero M, Diaz Gutierrez F, Reychler G. Short-term effects of hypertonic saline nebulization combined with oscillatory positive expiratory pressure in cystic fibrosis: randomised crossover trial. Journal of Cystic Fibrosis 2016;15 Suppl 1:S33. [Abstract no: WS21.3; CENTRAL: 1155402; CFGD Register: BD229a; CRS: 5500135000001528]5574071
125. San Miguel Pagola M, Herrero Cortina B, Cebria i Iranzo MA, Gomez Romero M, Diaz Gutierrez F, Reychler G. Hypertonic saline nebulization combined with oscillatory positive expiratory pressure accelerate sputum clearance in cystic fibrosis: A randomised crossover trial. European Respiratory Journal 2016;48(Suppl 60):PA1369. [CENTRAL: 1343707; CFGD Register: BD229b; CRS: 5500135000001897]5574072
126. Patel P, Fukushima L, Balekian A, Chou W, Lu A, Gali V, et al. Is Metaneb comparable to high frequency chest compression in the setting of a severe pulmonary exacerbation in adults with cystic fibrosis. Pediatric Pulmonology 2013;48 Suppl 36:359. [Abstract no: 420; CFGD Register: PE209; ]3312680
127. Wheatley CM, Baker SE, Daines C, Phan H, Morgan WJ, Snyder EM. Influence of the vibralung device on pulmonary function and sputum expectoration in patients with cystic fibrosis. Pediatric Pulmonology 2013;48 Suppl 36:357. [Abstract no: 416; CFGD Register: PE208; ]3312682
128. Cantin A. Cystic fibrosis lung inflammation: early, sustained, and severe. American Journal of Respiratory and Critical Care Medicine 1995;151(4):939-41.
129. Chevaillier J. Autogenic drainage. In: Lawson D editor(s). Cystic Fibrosis: Horizons. London: Churchill Livingstone, 1984:65-78.
130. Curtin F, Altman DG, Elbourne E. Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes. Statistics in Medicine 2002;21:2131-44.
131. Curtin F, Altman DG, Elbourne E. Meta-analysis combining parallel and cross-over clinical trials. III: The issue of carryover. Statistics in Medicine 2002;21:2161-73.
132. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9.
133. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
134. Higgins JPT, Altman DG, Sterne JAC on behalf of the CSMG and the CBMG, editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from cochrane.handbook.org.
135. Jüni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323(7303):42-6.
136. Konstan MW, Berger M. Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatric Pulomonolgy 1997;24(2):137-42.
137. Main E, Prasad A, van der Schans C. Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis. Cochrane Database of Systematic Reviews 2005, Issue 1. [DOI: 10.1002/14651858.CD002011.pub2]
138. McIlwaine M, Button B, Dwan K. Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis. Cochrane Database of Systematic Reviews 2015, Issue 6. [DOI: 10.1002/14651858.CD003147.pub4]
139. Mckoy NA, Wilson LM, Saldanha IJ, Odelola OA, Robinson KA. Active cycle of breathing technique for cystic fibrosis. Cochrane Database of Systematic Reviews 2016, Issue 7. [DOI: 10.1002/14651858.CD007862.pub4]
140. Prasad SA. Current concepts in physiotherapy. Journal of the Royal Society of Medicine 1993;86(Suppl 20):23-9.
141. Pryor J. Physiotherapy for airway clearance in adults. European Respiratory Journal 1999;14(6):1418-24.
142. Radtke T, Nolan SJ, Hebestreit H, Kriemler S. Physical exercise training for cystic fibrosis. Cochrane Database of Systematic Reviews 2015, Issue 6. [DOI: 10.1002/14651858.CD002768.pub3]
143. Rogers D, Doull IJM. Physiological principles of airway clearance techniques used in the physiotherapy management of cystic fibrosis. Current Paediatrics 2005;15(3):233-8.
144. Rosenfeld M, Emerson J, Williams-Warren J, Pepe M, Smith A, Montgomery AB, Ramsey B. Defining a pulmonary exacerbation in cystic fibrosis. Journal of Pediatrics 2001;139(3):359-65.
145. Schöni MH. Autogenic drainage: a modern approach to physiotherapy in cystic fibrosis. Journal of Royal Society of Medicine 1989;82(Suppl 16):32-7.
146. Volsko TA, DiFiore JM, Chatburn RL. Performance comparison of two oscillatory positive pressure devices: Acapella versus Flutter. Respiratory Care 2003;48(2):124-30.
147. Warwick WJ, Hansen LG. The long-term effect of high frequency chest compression therapy on pulmonary complications of cystic fibrosis. Pediatric Pulmonology 1991;11(3):265-71.
148. Webb AK, Dodd ME, Moorcroft J. Exercise and cystic fibrosis. Journal of the Royal Society of Medicine 1995;88(Suppl 25):30-6.
149. Webber BA, Hofmeyer JL, Moran MDL, Hodson ME. Effects of postural drainage, incorporating forced expiration technique, on pulmonary function in cystic fibrosis. British Journal of Diseases of the Chest 1986;80(4):353-9.
150. Webber BA. The active cycle of breathing exercises. Cystic Fibrosis News 1990;Aug/Sept:10-1.
151. Williams, EJ. Experimental designs balanced for the estimation of residual effects of treatments. Australian Journal of Scientific Research 1949;Series A, Volume 2:149-68.
152. Zach MS. Lung disease in cystic fibrosis - an updated concept. Pediatric Pulmonology 1990;8(3):188-202.
153. Morrison L, Agnew J. Oscillating devices for airway clearance in people with cystic fibrosis. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD006842]
154. Morrison L, Agnew J. Oscillating devices for airway clearance in people with cystic fibrosis. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD006842.pub2]
155. Morrison L, Agnew J. Oscillating devices for airway clearance in people with cystic fibrosis. Cochrane Database of Systematic Reviews 2014, Issue 7. [DOI: 10.1002/14651858.CD006842.pub3]